The Trump administration's approach to HIV prevention funding has been a subject of significant debate and scrutiny. Initially, the admi...

YOUNGSTOWN, Ohio – As part of its 150th anniversary celebration, the Mahoning Valley Historical Society hosted its June edition of “Bites an...

GAZA: The United Arab Emirates via “Operation Chivalrous Knight 3”, has delivered a new batch of emergency medical aid to health facilities...

Higher rates of cancers associated with immunosuppression in ethnically minoritized men living with HIV highlight gaps in HIV diagnosis and...

GREENVILLE, Miss. — Cedric Sturdevant woke up with “a bit of depression” but made it to church, as he does every Sunday. In a few days, he w...

The recent approval of lenacapavir, marketed as Yeztugo, by the FDA marks a pivotal advancement in HIV prevention strategies. As the first a...

The recent approval of lenacapavir, marketed as Yeztugo, by the FDA marks a pivotal advancement in HIV prevention strategies. This injectabl...

New Delhi:  While Gilead Sciences’ HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made-in-In...

All products and services featured are independently chosen by editors. However, Billboard may receive a commission on orders placed throu...

The EMA extension of indication recommendation will contribute to protection of public health beyond the EU. Medscape Medical News

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect...

Twice a year dosing shows potential for improved PrEP uptake and adherence. Medscape Medical News

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication

HONG KONG, June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Scienc...